MedTrace Logo

A Study of MK-7240 in Healthy Participants (MK-7240-009)

NCT07405177 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.

Conditions

  • Healthy

Interventions

BIOLOGICAL

Tulisokibart Form 1

Solution for injection.

BIOLOGICAL

Tulisokibart Form 2

Solution for injection.

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-05
Primary Completion
2026-09-03
Completion
2026-09-03
FDA Drug
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07405177 on ClinicalTrials.gov